Follicular lymphoma is a fascinating disease with remarkable biological features and a prolonged, often chronic, clinical course for most patients, adding further complexity when considering clinically relevant study endpoints. Despite its limitations, progression-free survival remains a useful and reproducible criterion to decipher the underlying biology that accounts for the heterogeneous outcome of patients and to assess the efficacy of new treatments.
https://ift.tt/2J2DBxk
Πέμπτη 31 Μαΐου 2018
[Correspondence] Predictive gene-expression score for follicular lymphoma – Authors' reply
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου